News Releases

Newsroom
In the News
News Releases
Media Coverage
Resources for Journalists

News Releases

Share
Share
and/or
458 News Releases found
Memorial Sloan Kettering Cancer Center (MSK) today announced the launch of a new digital patient experience through MSK Direct, a national cancer benefits solution for self-insured employers, labor unions, and health plans.
Memorial Sloan Kettering Cancer Center Broadens Access to Its Cancer Care Expertise With the Launch of Expanded Services for MSK Direct Members

Memorial Sloan Kettering Cancer Center (MSK) today announced the launch of a new digital patient experience through MSK Direct, a national cancer benefits solution for self-insured employers, labor unions, and health plans. With this launch, MSK Direct members will have seamless access through the MSK Direct app to virtual cancer support services, including expert medical opinions and 24/7 cancer care coaching and navigation.
Memorial Sloan Kettering Cancer Center Statement on Affirmative Action

“The recent ruling by the Supreme Court in the cases of Students for Fair Admissions Inc. v. President and Fellows of Harvard College and Students for ...
Shelly Anderson, MPM
Shelly Anderson Named Memorial Sloan Kettering Cancer Center’s Inaugural Hospital President

Memorial Sloan Kettering Cancer Center (MSK) today announced that Shelly Anderson, MPM, will join the institution as the inaugural Hospital President on September 25. Anderson joins MSK from Brigham and Women’s Hospital (BWH) in Boston, where she has been a member of the executive leadership team since 2011, most recently serving as Executive Vice President and Chief Operating Officer.
MSK Awards & Appointments January 2023
MSK Awards & Appointments June 2023

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Deb Schrag
ASCO 2023: New Research from Memorial Sloan Kettering Cancer Center and Dana-Farber Brigham Cancer Center Finds that Radiation Can Be Safely Omitted in Select Patients with Locally Advanced Rectal Cancer

Deb Schrag, MD, MPH, gastrointestinal oncologist and Chair of the Department of Medicine, presented results from a randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total surgical excision for the treatment of patients with locally advanced rectal cancer.
Ingo Mellinghoff
ASCO 2023: New Research from Memorial Sloan Kettering Cancer Center Identifies Significant Treatment Advancement for Brain Tumors

Ingo K. Mellinghoff, MD, FACP, neuro-oncologist and Chair of the Department of Neurology, presented significant results from a phase III trial in patients with residual or recurrent grade 2 glioma with an IDH1/2 mutation.
MSK Awards & Appointments January 2023
MSK Awards & Appointments May 2023

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
MSK researchers presenting new research at ASCO 2023, include Carol Aghajanian, MD; Ingo K. Mellinghoff, MD, FACP; and Deb Schrag, MD, MPH
ASCO 2023: Memorial Sloan Kettering Cancer Center Experts to Present Leading Edge Research at the American Society of Clinical Oncology Annual Meeting

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2–6 in Chicago.
Marie-Josée and Henry R. Kravis
Memorial Sloan Kettering Cancer Center Announces $40M Gift To Establish The Marie-Josée Kravis Center for Cancer Immunobiology To Advance Immunotherapy Research

The Marie-Josée Kravis Center for Cancer Immunobiology (CCI), made possible by a generous $40 million gift from Henry R. Kravis to honor the visionary leadership of his wife, Marie-Josée Kravis, will establish a strategic research infrastructure that will seamlessly unite MSK scientists and physicians to further accelerate immunotherapy treatments for people with cancer.
Memorial Sloan Kettering Cancer Center Issues Statement on First Quarter 2023 Financial Results

Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its first quarter 2023 financial results today.